Higher Serum Levels of Type I Interferon Receptor in Adults with Chronic Hepatitis B Leading to Hepatitis B Surface Antigen Clearance

作者: Ashraf Mohamadkhani , Sima Besharat , Golnosh Gol-Jah Rad , Akbar Pour Dadash Asiabar , Gholamreza Roshandel

DOI: 10.5812/JJM.41319

关键词:

摘要: Background: Loss of hepatitis B surface antigen (HBsAg) in chronic (CHB) infection is a favorable outcome. Type I interferon (IFNI) has an essential role to fight virus infections when they bind the IFN-α/β receptor (IFNAR). Free-circulating IFNARs, known as IFNAR2, perform carrier proteins keep ligands from proteolysis well antagonists for ligand binding. Objectives: In this study, we evaluated HBsAg titer and IFNAR2 serum baseline subcohort Iranian HBeAg-negative patients with B. Methods: Sixty-four who spontaneously cleared 100 enrolled study assessment levels IFNAR2. Results: Serum were both powerfully associated loss HBsAg. The was significantly lower (333.72 ± 1300 IU/mL vs 3811 6779 IU/mL, P = 0.00) level higher (1.64 0.6 0.87 0.5 ng/mL, those compared CHB patients. Conclusions: These findings indicated association clearance virus-infected consequence, immune mechanisms related signaling might be responsible © 2017, Ahvaz Jundishapur University Medical Sciences.

参考文章(33)
Ashraf Mohamadkhani, Faegh Bastani, Samaneh Khorrami, Reza Ghanbari, Sareh Eghtesad, Maryam Sharafkhah, Ghodratollah Montazeri, Hossein Poustchi, Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection Hepatitis Monthly. ,vol. 15, pp. 0- 0 ,(2015) , 10.5812/HEPATMON.28315V2
Brian J. McMahon, Natural history of chronic hepatitis B - clinical implications. The Medscape Journal of Medicine. ,vol. 10, pp. 91- ,(2008)
SA Samarajiwa, NE Mangan, MP Hardy, PJ Najdovska, M, Dubach, D, Braniff, SJ, Owczarek, CM, Soluble IFN Receptor Potentiates In Vivo Type I IFN Signaling and Exacerbates TLR4-Mediated Septic Shock Journal of Immunology. ,vol. 192, pp. 4425- 4435 ,(2014) , 10.4049/JIMMUNOL.1302388
Hilke Brühl, Josef Cihak, Yvonne Talke, Manuel Rodriguez Gomez, Fabian Hermann, Nicole Goebel, Kerstin Renner, Jiří Plachý, Manfred Stangassinger, Susanne Aschermann, Falk Nimmerjahn, Matthias Mack, B‐cell inhibition by cross‐linking CD79b is superior to B‐cell depletion with anti‐CD20 antibodies in treating murine collagen‐induced arthritis European Journal of Immunology. ,vol. 45, pp. 705- 715 ,(2015) , 10.1002/EJI.201444971
Sima Besharat, Aezam Katoonizadeh, Shirin Moossavi, Zahra Darvishi, Gholamreza Roshandel, Hossein Poustchi, Ashraf Mohamadkhani, The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B. Journal of Medical Virology. ,vol. 88, pp. 647- 652 ,(2016) , 10.1002/JMV.24367
Gabriel R. Starbeck-Miller, Vladimir P. Badovinac, Daniel L. Barber, John T. Harty, Cutting Edge: Expression of FcγRIIB Tempers Memory CD8 T Cell Function In Vivo Journal of Immunology. ,vol. 192, pp. 35- 39 ,(2014) , 10.4049/JIMMUNOL.1302232
Norio Ogata, Tomoteru Kamimura, Hitoshi Asakura, Point mutation, allelic loss and increased methylation of c-Ha-Ras gene in human hepatocellular carcinoma Hepatology. ,vol. 13, pp. 31- 37 ,(1991) , 10.1002/HEP.1840130106
G Fattovich, L Brollo, G Giustina, F Noventa, P Pontisso, A Alberti, G Realdi, A Ruol, Natural history and prognostic factors for chronic hepatitis type B. Gut. ,vol. 32, pp. 294- 298 ,(1991) , 10.1136/GUT.32.3.294
Hanns F. Löhr, Wolfgang Weber, Jörg Schlaak, Bernd Goergen, Karl-Hermann Meyer Zum Büschenfelde, Guido Gerken, Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e—minus hepatitis B virus mutants☆☆☆ Hepatology. ,vol. 22, pp. 61- 68 ,(1995) , 10.1002/HEP.1840220110